Page last updated: 2024-10-31

clorgyline and Leukemia

clorgyline has been researched along with Leukemia in 1 studies

Clorgyline: An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE.
clorgyline : An aromatic ether that is the 2,4-dichlorophenyl ether of 3-aminopropan-1-ol in which the nitrogen is substituted by a methyl group and a prop-1-yn-3-yl group. A monoamine oxidase inhibitor, it was formerly used as an antidepressant.

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Menna, M1
Fiorentino, F1
Marrocco, B1
Lucidi, A1
Tomassi, S1
Cilli, D1
Romanenghi, M1
Cassandri, M1
Pomella, S1
Pezzella, M1
Del Bufalo, D1
Zeya Ansari, MS1
Tomašević, N1
Mladenović, M1
Viviano, M1
Sbardella, G1
Rota, R1
Trisciuoglio, D1
Minucci, S1
Mattevi, A1
Rotili, D1
Mai, A1

Other Studies

1 other study available for clorgyline and Leukemia

ArticleYear
Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models.
    European journal of medicinal chemistry, 2022, Jul-05, Volume: 237

    Topics: Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Histone Demethylases; Humans; Leukemia

2022